Healthcare provider profile · identity verified

James Edward Erickson, MD

Family Practice · WARROAD, MN · NPI 1427586312

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	465	106
Losartan Potassium	Losartan Potassium	443	97
Lisinopril	Lisinopril	402	79
Rosuvastatin Calcium	Rosuvastatin Calcium	390	92
Amlodipine Besylate	Amlodipine Besylate	387	84
Levothyroxine Sodium	Levothyroxine Sodium	348	55
Metoprolol Succinate	Metoprolol Succinate	292	52
Metformin Hcl	Metformin Hcl	282	59
Gabapentin	Gabapentin	247	37
Jantoven	Warfarin Sodium	235	25
Tamsulosin Hcl	Tamsulosin Hcl	196	42
Simvastatin	Simvastatin	192	36
Furosemide	Furosemide	162	28
Pantoprazole Sodium	Pantoprazole Sodium	157	31
Famotidine	Famotidine	143	27
Omeprazole	Omeprazole	142	40
Hydrochlorothiazide	Hydrochlorothiazide	118	32
Metoprolol Tartrate	Metoprolol Tartrate	104	25
Sertraline Hcl	Sertraline Hcl	103	19
Allopurinol	Allopurinol	90	15
Citalopram Hbr	Citalopram Hydrobromide	89	12
Klor-Con M10	Potassium Chloride	89	12
Eliquis	Apixaban	85	17
Carvedilol	Carvedilol	82	19
Oxycodone Hcl	Oxycodone Hcl	80	23
Valsartan	Valsartan	79	14
Pravastatin Sodium	Pravastatin Sodium	78	17
Alendronate Sodium	Alendronate Sodium	75	19
Clopidogrel	Clopidogrel Bisulfate	75	16
Klor-Con M20	Potassium Chloride	65	11
Torsemide	Torsemide	57	suppressed
Trazodone Hcl	Trazodone Hcl	57	14
Duloxetine Hcl	Duloxetine Hcl	56	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	55	16
Escitalopram Oxalate	Escitalopram Oxalate	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	15
Spiriva Handihaler	Tiotropium Bromide	53	suppressed
Montelukast Sodium	Montelukast Sodium	51	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	50	15
Chlorthalidone	Chlorthalidone	49	suppressed
Labetalol Hcl	Labetalol Hcl	48	suppressed
Potassium Chloride	Potassium Chloride	48	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	46	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	suppressed
Mounjaro	Tirzepatide	45	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	suppressed
Tramadol Hcl	Tramadol Hcl	44	suppressed
Xarelto	Rivaroxaban	43	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	40	suppressed
Ondansetron Odt	Ondansetron	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Meloxicam	Meloxicam	38	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Estradiol	Estradiol	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	34	15
Fluticasone Propionate	Fluticasone Propionate	34	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Bupropion Xl	Bupropion Hcl	32	11
Glimepiride	Glimepiride	32	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Fluocinonide	Fluocinonide	30	14
Metformin Hcl Er	Metformin Hcl	30	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	30	suppressed
Bumetanide	Bumetanide	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Finasteride	Finasteride	28	suppressed
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Ozempic	Semaglutide	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Divalproex Sodium Er	Divalproex Sodium	26	suppressed
Glipizide	Glipizide	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Carbamazepine	Carbamazepine	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Prednisone	Prednisone	23	18
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Atenolol	Atenolol	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Digoxin	Digoxin	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	17
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	16	16
Prazosin Hcl	Prazosin Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Fentanyl	Fentanyl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Metolazone	Metolazone	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Nystatin	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error